The legacy status of Viagra, and its parent firm copyright, presents a intriguing question for investors . While earnings initially soared , the impending patent expiration and growing generic competition https://martinauvbr848843.targetblogs.com/41822984/the-blue-pill-and-pharma-a-speculative-investment